10.51USD-0.85%Mkt Cap: 61.36M $P/E: 6.411d ago
Daxor Corporation engages in medical instrumentation and biotechnology operations. It develops the BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume, in conjunction with Volumex, a single-use …
Industry Peers
Medical Instruments & SuppliesIndicators:|
Key Statistics
Company
Market Cap61.36M $
Enterprise Value—
Revenue (TTM)26.69K $
Gross Profit26.69K $
Net Income (TTM)9.17M $
Revenue/Share0.0050 USD
Last Price10.51 USD
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees—
CountryUS
SectorHealthcare
IndustryMedical Instruments & Supplies
ISIN—
Valuation
P/E (Trailing)6.41
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S2299.15
P/B1.16
EPS (TTM)1.64
EPS (Forward)—
52W Range
8.56031% of range14.76
52W High14.76 USD
52W Low8.560 USD
Profitability
Gross Margin100.00%
Oper. Margin-9660.55%
EBITDA Margin0.00%
Profit Margin89.00%
ROE19.98%
ROA19.93%
Growth
Revenue Growth-82.60%
Earnings Growth329.30%
Cash Flow & Leverage
Operating CF570.94K $
CapEx (TTM)—
FCF Margin375.63%
FCF Yield0.16%
Net Debt—
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio0.08
Quick Ratio—
Book Value/Sh9.069 USD
Cash/Share—
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield0.52%
Payout Ratio0.00%
Ex-Div DateJan 5, 2018
Pay DateJan 12, 2018
Analyst Consensus
Rating—
Target (Mean)22.50 USD
Upside (mean)+114.1%
Target Range22.00 USD – 23.00 USD
$22.00+114.1% to mean$23.00
# Analysts2
Ownership
Shares Out.5.84M
Float2.51M
Insiders49.46%
Institutions6.56%
Short Interest
Short Ratio0.5d
Short % Float0.04%
Short % Out.0.02%
Shares Short1.28K
Short (prev mo.)6.16K
Technical
SMA 5010.30 (+2.1%)
SMA 20011.76 (-10.7%)
Beta0.26
S&P 52W Chg20.25%
Avg Vol (30d)2.08K
Avg Vol (10d)1.40K
Technical Indicators
RSI (14)52.9
MACD0.0794
MACD Signal0.0320
MACD Hist.+0.0474
BB Upper10.92 USD
BB Middle10.22 USD
BB Lower9.511 USD
BB Width13.79%
ATR (14)0.4486 USD
Vol Ratio (20d)0.87x